| Literature DB >> 17078882 |
Ylanga G van der Geld1, Frank J Lagerwaard, John R van Sörnsen de Koste, Johan P Cuijpers, Ben J Slotman, Suresh Senan.
Abstract
BACKGROUND: 4-dimensional CT (4DCT) scans are increasingly used to account for mobility during radiotherapy planning. As variations in respiratory patterns can alter observed motion, with consequent changes in the generated target volumes, we evaluated the reproducibility of 4D target volumes generated during repeat uncoached quiet respiration.Entities:
Mesh:
Year: 2006 PMID: 17078882 PMCID: PMC1636642 DOI: 10.1186/1748-717X-1-43
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Volumetric and spatial comparison of PTV4DCT1 and PTV4DCT2
| 1 | 28.1 | 29.3 | 1.2 | 4.2 | 1.7 |
| 2 | 16.2 | 16.9 | 0.7 | 4.5 | 1.9 |
| 3 | 39.3 | 38.4 | 1.0 | -2.5 | 3.2 |
| 4 | 3.5 | 4.1 | 0.6 | 15.6 | 1.1 |
| 5 | 20.8 | 21.2 | 0.5 | 2.2 | 2.0 |
| 6 | 3.0 | 3.3 | 0.3 | 11.3 | 1.2 |
| 7 | 30.5 | 29.1 | 1.5 | -4.8 | 1.3 |
| 8 | 9.2 | 10.0 | 0.8 | 8.5 | 2.6 |
| 9 | 13.9 | 13.6 | 0.3 | -1.9 | 0.4 |
| 10 | 29.6 | 30.3 | 0.7 | 2.4 | 0.8 |
| 11 | 19.7 | 21.0 | 1.3 | 6.7 | 0.7 |
| 12 | 67.0 | 68.3 | 1.3 | 1.9 | 0.8 |
| 13 | 13.5 | 10.9 | 2.6 | -19.4 | 3.7 |
| 14 | 21.0 | 20.7 | 0.3 | -1.3 | 0.6 |
| 15 | 23.0 | 21.5 | 1.5 | -6.7 | 1.0 |
| 16 | 13.8 | 13.5 | 0.3 | -2.0 | 0.5 |
| 17 | 22.9 | 25.3 | 2.4 | 10.5 | 1.3 |
| 18 | 63.0 | 57.8 | 5.2 | -8.3 | 3.5 |
| 19 | 21.1 | 21.2 | 0.2 | 0.8 | 1.4 |
| 20 | 23.5 | 21.9 | 1.6 | -6.8 | 0.4 |
| 21 | 15.8 | 16.0 | 0.3 | 1.6 | 1.2 |
| 22 | 26.2 | 24.5 | 1.8 | -6.8 | 1.6 |
| 23 | 10.6 | 10.1 | 0.5 | -4.3 | 1.2 |
| 24 | 15.6 | 17.4 | 1.8 | 11.8 | 1.7 |
| 25 | 63.1 | 64.1 | 1.0 | 1.5 | 0.3 |
| 26 | 45.7 | 44.9 | 0.8 | -1.8 | 0.3 |
Percentage of each PTV encompassed by the 80% prescription isodose in a plan optimized for the other PTV.
| 1 | 97.8 | 98.2 |
| 2 | 96.3 | 97.1 |
| 3 | 98.6 | 95.2 |
| 4 | 97.8 | 96.9 |
| 5 | 93.0 | 99.6 |
| 6 | 96.9 | 92.9 |
| 7 | 98.9 | 98.3 |
| 8 | 90.7 | 93.4 |
| 9 | 98.8 | 98.9 |
| 10 | 98.9 | 97.2 |
| 11 | 97.4 | 100 |
| 12 | 99.9 | 100 |
| 13 | 97.6 | 82.5 |
| 14 | 99.2 | 99.3 |
| 15 | 98.8 | 95.4 |
| 16 | 99.4 | 99.6 |
| 17 | 93.9 | 99.5 |
| 18 | 99.3 | 91.2 |
| 19 | 99.5 | 99.8 |
| 20 | 100 | 98.1 |
| 21 | 99.3 | 98.1 |
| 22 | 98.8 | 93.9 |
| 23 | 98.1 | 97.6 |
| 24 | 94.8 | 100 |
| 25 | 98.8 | 98.3 |
| 26 | 100 | 99.8 |
Figure 1Mean dose-volume histogram for PTV coverage in 26 patients.
Figure 2Left panel: Coronal reconstruction of the end-expiration phase bin of patient 13, showing both PTV4DCT1(violet contour) and PTV4DCT2 (pink contour). Colorwash displays of the 80%, 60% and 20% isodoses show the most caudal area of PTV4DCT1 to lie in the 20% isodose area. Right panel: A corresponding color intensity projection in the same patient with the color bar providing time-related positional information (white = 100% presence; blue = 90%; green = 50%; orange = 10%). This indicates that the most caudal PTV region represents a site occupied by the tumor for 10–20% of the respiratory cycle.
Figure 3Respiratory waveforms during image acquisition for both 4DCT scans at the level of tumor in patient 13. Images were reconstructed from acquisitions at two consecutive couch positions (table increments of 2 cm) as evidenced by the discontinuous waveforms. The RPM amplitude at the end-expiration tumor position was similar in both 4DCT scans (A), but a larger difference in respiratory amplitude was seen at the end-inspiratory tumor position (B).